Survival With Olanzapine in Patients With Locally Advanced or Metastatic Upper Gastrointestinal and Lung Cancer

NCT06338683 · clinicaltrials.gov ↗

PHASE3

Phase

RECRUITING

Status

230

Enrollment

OTHER

Sponsor class

Conditions

Advanced Cancer
Olanzapine
Progression Free Survival

Interventions

DRUG: Olanzapine 2.5 MG
DRUG: Standard anti-tumor treatment
DIETARY_SUPPLEMENT: Nutritional advice

Sponsor

Qinghai Red Cross Hospital